Glenmark Generics Limited's (GGL) US subsidiary has received ANDA approval from the United States Food and Drug Administration (US FDA) for Betamethasone dipropionate cream, 0.05 per cent (augmented) and will soon commence marketing and distribution of this product in the US market.
The details can be read here.
No comments:
Post a Comment